The clinical data indicate that the expression of stroma-related genes, including IL-6, in biopsy specimens from patients treated with chemotherapy prior to surgery was significantly correlated with a poor response to chemotherapy in the GC patients. This evidence concerns the gene IL6 and gastric cancer.